Objective: We quantified the isolated impact of end-stage renal disease (ESRD) on physical performance under contemporary hemodialysis treatment independent of comorbid diseases, characterized principal anthropometric components, and adjusted for their influence and compared associations of C-reactive protein (CRP), albumin, and serum total iron-binding capacity (TIBC) with muscle function.
Design: A case-control cross-sectional study.
Setting: University medical hospital and outpatient hemodialysis units.
Subjects: Ninety prevalent hemodialysis patients without important comorbidities and 140 controls.
Main outcome measures: Handgrip strength (HGS) and 10-repetition sit-to-stand time (STS-10).
Results: Principal component analysis revealed 3 representative anthropometric measures to be included in explanatory models of muscle performance additional to body height: lean body mass, fat mass, and joint size. Controlling for these covariates, age, sex, and residual comorbidity, ESRD was associated with a modest 7.5% reduction in HGS (B = -2.57 kg; 95% confidence interval: -4.81 to -0.39; P = .005; model R(2) 0.74) and a relatively larger prolongation of 27% in STS-10 time (B = 4s; 95% confidence interval: 2.61 to 5.4; P < .001; model R(2) 0.53). Lean body mass and height significantly predicted both tests, fat mass, and wrist size predicted HGS. In the subgroup of dialysis patients, only TIBC showed a significant association with HGS independently from age, sex, wrist size, whereas CRP and albumin did not. STS-10 time was not associated with any of these biomarkers. Results remained stable in sensitivity analyses excluding patients with reported chronic regional motor difficulties and aches.
Conclusions: ESRD with contemporary hemodialysis therapy has a relatively modest negative comorbidity-free association with HGS and a larger effect on STS-10 lower extremity performance. Nonmodifiable anthropometric indices (body height and for HGS wrist size) have a significant independent impact and should be consistently adjusted for in future studies. In low-comorbidity dialysis patients, TIBC is a superior predictor of HGS compared with albumin and CRP.
Copyright © 2016 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.